Stocks Under $0.10: ITRM, PLYX, AMLM, BFRG, QNCX, ADMQ March Madness Watch Getting your Trinity Audio player ready... A group of sub-$0.10 and low-priced small-cap stocks is drawing increased attention as investors rotate into high-beta, low-float names across biotechnology,...

The Street Reports Sub-$0.10
thestreetreports.com/stocks-under...
#AMLM #BFRG #ADMQ #ITRM #PLYX #QNCX

A $5.5M payment erased Quince debt as it explores merger options All EIB loan and settlement obligations were discharged, removing an overhang the company said constrained flexibility as it evaluates strategic alternatives.

#QNCX Quince Therapeutics Settles Approximately $16.4 Million of Debt

www.stocktitan.net/news/QNCX/quince-therape...

Under-the-Radar Microcaps: ADM Endeavors (OTCQB: ADMQ) Textile Manufacturer in Texas – QNCX RENX JTAI FAGI to Watch Getting your Trinity Audio player ready... In the microcap investment universe, companies that combine real revenue, scalable infrastructure, and industry tailwinds often attract the attention of inve...

Under-the-Radar Microcaps: ADM Endeavors (OTCQB: #ADMQ ) Textile Manufacturer in Texas – #QNCX #RENX #JTAI #FAGI to Watch

thestreetreports.com/under-the-ra...

Under-the-Radar Microcaps: ADM Endeavors (OTCQB: ADMQ) Textile Manufacturer in Texas – QNCX RENX JTAI FAGI to Watch Getting your Trinity Audio player ready... In the microcap investment universe, companies that combine real revenue, scalable infrastructure, and industry tailwinds often attract the attention of inve...

#ADMQ Under-the-Radar Microcaps: ADM Endeavors (OTCQB: ADMQ) Textile Manufacturer in Texas –
thestreetreports.com/under-the-ra...
#QNCX #RENX #JTAI #FAGI

🚨 Institutions #optionsvolume surge detected! Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.

🚨 Institutions #optionsvolume surge detected!

Weekly Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #CRSR 303.8x
2. #QNCX 279.2x
3. #XENE 144.6x
4. #FTV 41.5x
5. #BWA 33.7x

#OptionFlow #OptionsTrading #Trading

Micro-Cap Under $1: TOON, PRSO, RENX, QNCX, KIDZ Building Momentum Getting your Trinity Audio player ready... As investors continue scanning the small-cap landscape for high-upside opportunities, a select group of stocks under $1 is drawing renewed market attention across semiconductors, media, environmental services, biotechnology, and education technology. With volatility creating opportunity in the micro-cap space, these companies are emerging as speculative names to watch. Kartoon Studios (NYSE […]

Micro-Cap Under $1: #TOON, #PRSO, #RENX, #QNCX, #KIDZ Building Momentum

thestreetreports.com/micro-cap-un...

Today’s most trending tickers with positive sentiment (last 24h):

#SPY: 26
#ASTS: 20
#QNCX: 16
#HOOD: 16
#MSFT: 14
#MCD: 11
#NXXT: 11
#GOOGL: 10
#AAPL: 8
#FSLY: 8
#TSLA: 8
#SEGG: 8
#META: 7
#MU: 7
#JUST: 7
#PLTR: 6
#APP: 6
#LITM: 6

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#QNCX, #XOM, #HPE, #WEN, #AEP

#OptionFlow #OptionsTrading #Trading

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus

🎯 Sweep Options Activity trade ideas! Institutions trading #options urgently with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#AVGO, #XOM, #QNCX, #SMR, #BABA

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected! PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #QNCX 370.0x
2. #XOM 36.4x
3. #HPE 12.5x
4. #WEN 9.8x
5. #AEP 9.2x

#OptionFlow #OptionsTrading #Trading

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expir

🎯 #UnusualOptionsActivity trade ideas! Strong census from institutions on #options with short expirations.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CVNA, #NBIS, #VKTX, #QNCX, #PEGA

#OptionFlow #OptionsTrading #Trading

BREAKING NEWS: ( NASDAQ: #QNCX ) US Companies Moving the Markets, Evening edition <br>Wed, Feb 11, 2026 as of 4:00 pm ET

📈 Heavy institution #Equity #optionsvolume! AM Top Equity Activity from 🔥 INSIDERFINANCE.COM 🔥 1

📈 Heavy institution #Equity #optionsvolume!

AM Top Equity Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #NVDA 192.2K
2. #TSLA 127.4K
3. #AAPL 51.4K
4. #AMZN 38.2K
5. #QNCX 28.5K

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected! AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #QNCX 243.4x
2. #SW 4.3x
3. #PRIM 2.6x
4. #LDI 2.6x
5. #CMBT 2.1x

#OptionFlow #OptionsTrading #Trading

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#QNCX, #SW, #PRIM, #LDI, #CMBT

#OptionFlow #OptionsTrading #Trading

Just In: ( NASDAQ: #QNCX ) US Companies Moving the Markets, Morning edition <br>Wed, Feb 11, 2026 as of 10.00 am ET

📢 Stocks Trending NOW: #VRT #U #SHOP #HOOD #KHC #TMUS #HUM #NET #LYFT #QNCX

Today’s most trending tickers with positive sentiment (last 24h):

#SPY: 25
#QNCX: 19
#GOOGL: 15
#SPOT: 15
#SEGG: 13
#TLT: 12
#NXXT: 12
#AMZN: 11
#HOOD: 11
#BTC: 10
#TSLA: 8
#NOW: 8
#ASTS: 8
#PLTR: 7
#NIO: 6
#IPW: 6
#QQQ: 6
#JUST: 6

#QNCX sees strong delivery numbers and large call flow, particularly at $7.5 Mar20 strike.

#QNCX Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia

www.stocktitan.net/news/QNCX/quince-therape...

Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders Quince Therapeutics (Nasdaq: QNCX) announced publication in Frontiers in Drug Delivery summarizing eight early-stage clinical trials of its lead asset eDSP (dexamethasone sodium phosphate encapsulated in autologous red blood cells) in pulmonary and inflammatory bowel disorders.Key findings: eDSP was dosed every two weeks or monthly across ages 5–83, produced improved FEV1 and fewer infections in cystic fibrosis, improved COPD symptoms with lower steroid exposure, enabled corticosteroid withdrawal in 60%–78% of IBD patients, and showed DSP levels persisting up to 28 days post-infusion; mean infusion dose did not exceed 10 mg.

#QNCX Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders

www.stocktitan.net/news/QNCX/quince-therape...

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily averag

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#CWH, #SLM, #EC, #ALGM, #QNCX

#OptionFlow #OptionsTrading #Trading

#QNCX Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

www.stocktitan.net/news/QNCX/quince-therape...

Quince Therapeutics Hits Major Milestone: Phase 3 A-T Trial Fully Enrolled, $35M to Fund Critical Results Key Phase 3 NEAT trial completes enrollment with 105 participants. Cash runway extended through Q2 2026. Strategic partnership secured for US launch. See full details.

#QNCX #OPCH Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/QNCX/quince-therape...

Quince Therapeutics Prepares Major Rare Disease Launch with 270+ Treatment Centers Nationwide Strategic deal unlocks 90+ pharmacies and 180+ infusion sites for rare disease treatment delivery. Learn how this impacts Quince's commercial launch plans.

#QNCX #OPCH Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

www.stocktitan.net/news/QNCX/quince-therape...

Major Breakthrough: Quince's Phase 3 Trial Could Deliver First-Ever Treatment for Rare Neurological Disease 105 patients enrolled in pivotal NEAT study for rare neurodegenerative disease treatment. FDA Fast Track designation secured. Key results expected Q1 2026. See timeline.

#QNCX Quince Therapeutics Completes Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

www.stocktitan.net/news/QNCX/quince-therape...

Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities Quince Therapeutics (QNCX) has secured a private placement of securities expected to generate $11.5 million in upfront proceeds, with potential additional proceeds of up to $10.4 million through warrant exercises. The financing, led by Nantahala Capital with participation from ADAR1 Capital Management and company management, is priced at $1.325 per share, a 10% premium over the previous closing price. The company will issue 8,671,928 shares of common stock with accompanying warrants exercisable at $1.20 per share. The proceeds will fund the ongoing Phase 3 NEAT clinical trial in Ataxia-Telangiectasia, along with general corporate expenses. Combined with existing funds, this financing is expected to extend Quince's operations into Q2 2026, or H2 2026 if warrants are fully exercised.

#QNCX Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities

www.stocktitan.net/news/QNCX/quince-therape...

#QNCX has surpassed 75% enrollment in its pivotal Phase 3 trial for a rare pediatric neurodegenerative disease. This marks a critical step toward delivering hope and potential treatment for affected children and families.
#Quince_Tx
prismmarketview.com/quince-thera...

FDA Fast-Tracked Rare Disease Drug Nears Full Phase 3 Enrollment with Strong Patient Retention Key milestone reached in pivotal Phase 3 NEAT trial for Ataxia-Telangiectasia treatment. 100% patient retention in extension study. See NDA timeline.

#QNCX Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia

www.stocktitan.net/news/QNCX/quince-therape...

Quince Therapeutics Eyes Capital-Efficient Path to NEAT Data as A-T Trial Nears Enrollment Milestone Strategic Shift Aims to Maximize Resources and Deliver Phase 3 Data by Early 2026 Quince Therapeutics (NASDAQ: QNCX) reported first quarter 2025 results whil

Quince Therapeutics #QNCX is considering an early enrollment close for its Phase 3 NEAT trial of EryDex in A-T to align with its current cash runway.
#QuinceTherapeutics
Read more: prismmarketview.com/quince-thera...